Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/29/25 13:13 | 10/27/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Fmr LLC | MA | TH | See Rema | 1 | S | -12 | 26.68 | 0 | 0 | 0 | 1,981 | I | ||||||||||||||
10/3/25 16:15 | 10/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Cavanagh Bethany J | MA | O | SVP,Fina | 1 | S | -11 | 24.53 | 0 | 0 | 44 | D | |||||||||||||||
10/3/25 16:10 | 10/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Bellon Christine | MA | O | GC | 1 | S | -9 | 24.53 | 0 | 0 | 0 | 117 | D | ||||||||||||||
10/3/25 16:05 | 10/1/25 | BEAM | Health | BioPrd | Biological Products, (No Diag | Evans John M. | MA | DO | CEO | 1 | S.dm | -1,228 | 24.57 | 0 | -50 | 1,090 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |